Careplus Group Bhd

Careplus Group Bhd

0163 · KLSE · Healthcare / Medical Instruments & Supplies

0.075MYR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.075
Open0.075
Day Range0.07 – 0.08
52-Week Range0.06 – 0.11
Volume1.26M
Market Cap67.97M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta0.02
50-Day Avg0.0766
200-Day Avg0.0772

About

Careplus Group Berhad, an investment holding company, manufactures and processes gloves in South America, North America, Malaysia, rest of Asia Pacific, and internationally. It offers latex exam gloves for use in medical examinations and procedures, diagnostic procedures by dentists, laboratory practices, and food handling practices; Nitrile examination gloves; and surgical gloves. The company also manufactures rubber gloves; manufactures, imports, and exports various types of hand gloves; develops and installs solar generation facilities; provides gloves packaging and warehousing services; offers hostel management and consultancy services, as well as involved in repairs and maintains buildings and its related works. In addition, it sells and deals in electric vehicles. Further, the company offers manufactures and assemblies new energy vehicles and leases and operates passenger cars. Additionally, it is involved in maintenance, repair, and sale of motor vehicles. Careplus Group Berhad was founded in 1988 and is based in Seremban, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Kwee Shyan Lim
  • Employees0
  • HeadquartersLorong Senawang 3/2, Seremban, Malaysia, 70450, Malaysia
  • Websitehttps://www.careplus.com

Leadership

  • Mr. Kwee Shyan LimGroup CEO & Executive Director · b. 1963
  • Mr. Teck Looi LooNon-Independent Executive Director · b. 1974
  • Mr. Chee Keong LimFinance Manager · b. 1971
  • Mr. Boon Keong KhooChief Administrative Officer · b. 1974
  • Ms. Sor Hua TeaCompany Secretary · b. 1971
  • Madam A. Ley LimGroup Financial Controller & Joint Secretary · b. 1967
  • Mr. Hui Yan Loo MAICSAJoint Secretary

Financials

Income Statement

Currency: MYR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue47.23M55.40M97.39M129.06M152.15M190.26M229.44M322.57M338.71M365.11M475.63M700.21M204.93M84.95M98.93M105.35M
Growth (%)-+17.30%+75.81%+32.51%+17.89%+25.05%+20.59%+40.59%+5.00%+7.79%+30.27%+47.22%-70.73%-58.55%+16.46%+6.49%
Cost of Revenue40.08M53.80M86.74M117.51M132.19M162.05M207.93M302.23M317.71M357.18M340.08M415.47M274.81M103.96M120.60M102.96M
Gross Profit7.15M1.60M10.65M11.54M19.95M28.21M21.51M20.34M21.00M7.93M135.55M284.74M-69.88M-19.01M-21.67M2.39M
Gross Margin15.13%2.88%10.94%8.94%13.11%14.83%9.37%6.31%6.20%2.17%28.50%40.66%-34.10%-22.38%-21.90%2.27%
Operating Expense4.01M593.84K6.54M6.35M9.71M11.84M11.65M9.47M9.44M10.68M-16.62M6.38M4.67M3.37M11.96M10.81M
Operating Income3.13M1.00M4.12M5.19M10.25M16.38M9.86M10.87M11.56M-2.74M152.18M278.36M-74.55M-22.38M-33.63M-8.42M
Operating Margin6.63%1.81%4.23%4.02%6.73%8.61%4.30%3.37%3.41%-0.75%31.99%39.75%-36.38%-26.34%-33.99%-7.99%
EBITDA4.06M3.27M8.67M11.48M17.89M28.00M25.00M32.26M32.40M17.73M167.92M300.81M-49.33M-4.39M-63.15M-2.64M
EBITDA Margin8.60%5.91%8.91%8.90%11.76%14.72%10.90%10.00%9.57%4.86%35.31%42.96%-24.07%-5.17%-63.83%-2.51%
Net Income3.14M1.98M2.97M1.27M3.17M6.00M159.16K-1.92M-1.42M-7.82M122.47M220.91M-147.16M-26.57M-81.63M-11.72M
Net Income Margin6.65%3.57%3.05%0.99%2.08%3.15%0.07%-0.59%-0.42%-2.14%25.75%31.55%-71.81%-31.28%-82.51%-11.13%
Interest Expense242.24K584.23K1.36M2.35M2.74M3.36M4.74M5.11M5.47M5.19M3.63M2.32M2.24M2.69M2.35M1.49M
Interest Expense % of Total Revenue0.51%1.05%1.39%1.82%1.80%1.77%2.06%1.59%1.61%1.42%0.76%0.33%1.09%3.17%2.38%1.42%

Balance Sheet

Currency: MYR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets41.12M69.55M121.58M138.05M162.91M210.82M293.82M286.57M297.73M272.15M442.19M608.00M360.61M361.25M286.61M271.39M
Total Liabilities10.75M25.77M68.39M80.35M98.03M127.06M172.00M155.73M159.17M175.52M179.78M122.33M92.06M80.18M71.48M62.37M
Total Equity30.37M35.25M42.34M43.61M46.78M60.62M92.93M97.97M101.93M96.63M262.03M485.30M268.13M282.48M216.26M210.47M
Cash6.50M1.18M7.91M6.75M2.98M4.50M6.76M5.81M8.73M5.70M30.09M38.80M90.99M31.31M15.42M8.34M
Total Debt6.71M16.63M43.86M56.81M61.82M79.29M112.73M104.93M108.96M87.15M30.94M21.17M45.93M45.80M31.38M31.60M
Net Debt214.36K15.45M35.96M50.06M58.84M74.79M105.97M99.12M100.24M81.45M849.82K-17.63M-45.05M14.49M15.96M23.26M

Cash Flow

Currency: MYR2010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow2.06M-1.55M-4.74M-355.76K19.81M17.69M4.18M7.97M13.52M47.79M149.07M181.89M-36.74M-67.47M1.98M5.89M
Investing Cash Flow-11.11M-12.03M-14.53M-12.51M-17.51M-31.37M-30.38M-13.04M-12.70M-19.99M-94.26M-115.58M15.70M-22.16M-17.78M-20.58M
Financing Cash Flow12.34M6.76M31.18M7.93M-2.93M15.37M39.50M-4.61M-430.23K-31.75M3.95M-8.72M-15.28M29.70M19.17M6.95M
Capital Expenditure11.82M26.28M17.70M12.59M17.63M32.10M30.71M13.87M14.03M14.63M99.03M123.07M14.43M22.08M21.80M24.48M
Free Cash Flow-9.76M-27.83M-22.44M-12.94M2.18M-14.41M-26.53M-5.90M-504.20K33.16M50.04M58.82M-51.17M-89.55M-19.83M-18.59M
Dividends Paid4.00M--587.50K-595.04K1.21M0--2.70M33.36M0---
FCF to OCF-473.69%1791.97%473.43%3638.11%10.99%-81.45%-635.05%-74.09%-3.73%69.38%33.57%32.34%139.28%132.73%-1003.95%-315.49%
Dividend Paid to FCF-40.98%---4.54%--4.13%-4.55%0.00%--5.40%56.72%0.00%---

Earnings

Report DateJan 31, 2011Apr 30, 2011Jul 31, 2011Oct 31, 2011Jan 31, 2012Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------------------------------------------
EPS Actual-0.000.000.01-0.00-0.000.000.00-0.000.000.010.000.000.000.000.00-0.010.000.01-0.01-0.00-0.00-0.00-0.000.00-0.000.00-0.00-0.010.000.000.070.080.080.230.200.02-0.03-0.07-0.06-0.05-0.03-0.03-0.14-0.02-0.01-0.01-0.00-0.01-0.01-0.01-0.08-0.00-0.00-0.00-0.01
Surprise-------------------------------------------------------
Timing-------------------------------------------------------

Key Statistics & Ratios

Market Cap67.97M
Enterprise Value95.48M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.65
Price / Book0.34
EPS-0.02
Book Value0.27
Revenue (TTM)105.35M
Gross Profit (TTM)2.39M
EBITDA-4.32M
Profit Margin-11.13%
Operating Margin-17.53%
Return on Equity-5.69%
Return on Assets-2.23%
Shares Outstanding849.63M
Shares Float553.28M
Beta0.02
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20213×
0.02Aug 30, 20210.02May 27, 20210.02Mar 5, 2021
20201×
0.01Jul 8, 2020
20161×
0.00Jun 20, 2016
20151×
0.00Jul 3, 2015
20131×
0.00Jul 8, 2013

Stock Splits

  • Jul 22, 2015479156:319437